David J. Goldberg, M.D., discusses what constitutes wrongful termination in this Legal Eagle article.
If the public pays for the training of physicians, can it be argued that the public has an ownership property interest in American healthcare? David J. Goldberg, M.D., J.D., provides his insight.
In this Legal Eagle article, Dr. Goldberg discusses the intricacies of the physician-patient relationship, and how that relationship can still be formed even if you never see the patient.
Teledermatology can be a major part of some dermatology practices. In this Legal Eagle article, Dr. Goldberg discusses the liability issues surrounding telemedicine that could put you and your practice at risk.
How far can drug companies go with off-label promotion? Dr. Goldberg addresses this and more in his latest Legal Eagle column.
The Food, Drug and Cosmetic Act (FDCA) gives the U.S. Food and Drug Administration (FDA) the authority to ensure that drug/device promotion is not false and/or misleading. But does that mean the FDA can regulate physician comments on drugs and devices? Dr. Goldberg provides his insight in this month's Legal Eagle column.
In this follow up to last month’s Innovations column on intellectual property and technology transfer, Raymond A. Miller, J.D., and Steve Xu, M.D., FAAD discuss how to utilize patents to maximize value for your venture.
David J. Goldberg, M.D., J.D., discusses the Family and Medical Leave Act (FMLA) and what you should know to protect yourself and your practice.
It is common knowledge that both not-for-profit and for-profit hospitals across the U.S. have policies of charging uninsured patients more. And some physicians have done the same. But patients are starting to question these policies, landing some hospitals and physicians in hot water.
In this month's Legal Eagle column, David J. Goldberg, M.D., J.D., offers his insight on when to settle a malpractice lawsuit outside of court and when to take take it to trial.